Cidara Therapeutics
CDTX
CDTX
44 hedge funds and large institutions have $25.2M invested in Cidara Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-9
Holders Change %
-16.98%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
13
Reduced
14
Closed
13
Calls
$41K
Puts
–
Net Calls
+$41K
Net Calls Change
-$21K
Top Buyers
Top Sellers
| 1 |
Two Sigma Advisers
New York
|
-$327K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$263K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$252K |
| 4 |
Two Sigma Investments
New York
|
-$195K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$185K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECM
51
ExodusPoint Capital Management
New York
| – | -$15K | -577 | Closed |
|
|
CP
52
Castleview Partners
Dallas,
Texas
| – | -$5.5K | -349 | Closed |
|
53
Optiver Holding
Amsterdam,
Netherlands
| – | -$11K | -255 | Closed |
|
|
TSWM
54
Tyler-Stone Wealth Management
Beachwood,
Ohio
| – | -$1K | -38 | Closed |
|